Monoclonal Antibody Therapy Plus Etoposide in Treating Patients With Neuroblastoma
Clinical trial NCT00004110 · COMPLETED
Trial details
- NCT number
- NCT00004110
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 1999-08-01
- Primary completion
- 2004-09-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.